Explore: Biotech · Drug Discovery · AI Infrastructure · Diagnostics · Pre-Seed · Seed · Series A
Yosemite Fund II
Yosemite
VC$200MCo-investsLeads rounds
Fund Size
$200M
Check Size
$1.0M→$10.0M
Location
🇺🇸United States
Activity
Statusactively investing
Links
Investment Thesis
Oncology-focused venture firm building biotech companies from scratch out of early academic research using a mix of philanthropy and outside investment capital. Uses AI for drug discovery and clinical trial design.
About Yosemite Fund II
Yosemite is a venture capital firm focused on investing in innovative solutions that address cancer, with a mission to transform the landscape of cancer treatment and care.
Sectors
BiotechDrug DiscoveryAI InfrastructureDiagnostics
Stages
pre-seedseedSeries ASeries B
Geographic focus
United States
Notable Investments
Turquoise Health, Tune Therapeutics, Shinobi Therapeutics, TigaTx, Daymark Health, Maia Oncology
Verified 13 July 2026 · Sources: company website, Fusion42 review
Frequently asked questions
- What does Yosemite Fund II invest in?
- Yosemite Fund II invests in Biotech, Drug Discovery, AI Infrastructure and Diagnostics at the pre-seed, seed, series-a and series-b stages.
- Which geographies does Yosemite Fund II focus on?
- Yosemite Fund II focuses on United States, and is headquartered in United States.
- What is Yosemite Fund II's typical check size?
- Yosemite Fund II typically writes checks of $1M to $10M.